Fingerprint
Dive into the research topics of 'Potential mechanisms of human natural killer cell expansion in vivo during low-dose IL-2 therapy'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Potential mechanisms of human natural killer cell expansion in vivo during low-dose IL-2 therapy
Todd A. Fehniger, Eric M. Bluman, Michelle M. Porter, Ewa Mrózek, Megan A. Cooper, Jeffrey B. VanDeusen, Stanley R. Frankel, Wendy Stock, Michael A. Caligiuri
- Roy and Diana Vagelos Division of Biology & Biomedical Sciences (DBBS)
- Institute of Clinical and Translational Sciences
- Siteman Cancer Center
- COVID-19 Researchers
- Bursky Center for Human Immunology & Immunotherapy Programs (CHiiPs)
- Division of Rheumatology
- Section of Stem Cell Biology
- Rheumatic Diseases Research Resource-Based Center
- DBBS - Immunology
- DBBS - Human and Statistical Genetics
- DBBS - Cancer Biology
Research output: Contribution to journal › Article › peer-review
80
Scopus
citations